(S)-2-(((Benzyloxy)carbonyl)amino)-3-(2-fluorophenyl)propanoic acid, 95.0%, 5g

7-Bromo-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione, 97.0%, 250mg

N-ETHOXYCARBONYL-L-PHENYLALANINE, 95.0%, 5g

4,5,6,10,12-pentaazatricyclo[7.3.0.0�,?]dodeca-1,3(7),4,8-tetraen-11-one, 97%, 1g

(S)-2-(3-(Pyridin-2-ylmethoxy)pyrrolidin-1-yl)-5-(trifluoromethyl)benzoic acid, 98%, 100mg

1-(N-Methylpiperidin-4-yl-methyl)piperazine, 98.0%, 1g

Ethyl 3-(4-fluorophenyl)-1H-pyrazole-5-carboxylate, 95.0%, 1g

Magnesium sulfate, min. 98%, pa, anhydrous, granulated, 100 g, glass packaging

6-Bromo-4-chloro-7-methoxyquinazoline, 95%, 1g

N-(4-(indolinylsulfonyl)phenyl)ethanamide, 95%, 2g

4-Decenoic Acid>98.0%(GC)(T)5mL

2-((4-[(2-METHOXYBENZOYL)AMINO]BENZOYL)AMINO)BENZOIC ACID, 95%, 50mg

1,4,7-Trioxacyclotridecane-8,13-dione, 95.0%, 50mg